Why is Eiko Lifescience falling/rising?

As of 17-Nov, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 53.10, reflecting a decrease of Rs 1.65 or 3.01%. The stock has underperformed its sector by 3.43% today and has been on a consecutive downward trend for the last two days, with a total drop of 3.47% in that period. Although the stock opened with a gain of 3.18% and reached an intraday high of Rs 56.49, it also touched a low of Rs 52.68, indicating significant volatility. The stock's performance over the past week shows a decline of 6.63%, while it has gained 4.63% over the past month. However, year-to-date, it has fallen by 15.36%, contrasting with the Sensex's gain of 8.72% during the same period. The stock is currently trading above its 200-day moving average but below its shorter-term moving averages, suggesting mixed signals regarding its trend. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 47.54% against the 5-day average.
In the broader market context, Eiko Lifesciences' recent performance has been significantly weaker compared to the benchmark Sensex, which has gained 1.69% over the past week. This underperformance is compounded by the stock's year-to-date decline of 15.36%, while the Sensex has shown a positive return of 8.72%. The liquidity of the stock remains adequate for trading, but the falling investor participation may indicate waning interest, which could further pressure the stock price. Overall, the combination of recent price movements, declining investor engagement, and the stock's inability to keep pace with the benchmark suggests a challenging environment for Eiko Lifesciences Ltd.